About Dr. Mandeep Singh Malhotra
Dr. Mandeep Singh Malhotra is a Senior Oncologist at CK Birla Hospital, New Delhi — a modern, JCI-standard hospital offering comprehensive cancer care. He is a highly experienced cancer specialist with expertise across multiple oncology disciplines, with particular focus on breast cancer, lung cancer, and gastrointestinal malignancies.
Dr. Mandeep Singh Malhotra — Cancer Specialist, CK Birla Hospital Delhi trained at top oncology institutes in India and brings a multidisciplinary approach to cancer care — working closely with surgical oncologists, radiation oncologists, and pathologists to develop individualised treatment plans for each patient. He is experienced in administering chemotherapy, targeted therapy, immunotherapy, and hormonal therapy for various cancer types.
CK Birla Hospital’s oncology department is equipped with advanced infusion facilities, port placement services, and dedicated day-care chemotherapy units — allowing most patients to receive treatment without lengthy hospital stays. This is particularly valuable for international patients from Kazakhstan and CIS countries who may need to manage their treatment in cycles with travel between sessions.
Conditions Treated
Consult Dr. Mandeep Singh Malhotra, Oncologist at CK Birla Hospital Delhi, who specialises in the diagnosis and treatment of:
- Breast Cancer — all stages, including triple-negative and HER2-positive
- Lung Cancer — NSCLC and SCLC, targeted therapy based on mutation profiling
- Colorectal and Gastrointestinal Cancers
- Cervical and Gynaecological Cancers
- Head and Neck Cancers
- Lymphoma — Hodgkin and Non-Hodgkin
- Chemotherapy administration — all major regimens
- Targeted Therapy — EGFR, HER2, ALK, PD-L1 inhibitors
- Immunotherapy — Pembrolizumab, Nivolumab, Atezolizumab
- Cancer Pain Management and Palliative Oncology
Why Kazakhstan & CIS Patients Choose Dr. Mandeep Singh Malhotra
For patients in Kazakhstan and CIS countries, access to advanced cancer treatments like targeted therapy and immunotherapy may be limited by availability, cost, or waiting times. In India, these treatments are available immediately at CK Birla Hospital through Dr. Mandeep Singh Malhotra, at costs 60 to 70 per cent lower than in Europe.
Chemotherapy cost in India: $250 to $600 per cycle depending on regimen. In Kazakhstan private hospitals: $800 to $1,500 per cycle. Targeted therapy agents like Trastuzumab, Erlotinib, and Pembrolizumab are available at significantly lower prices in India due to generic manufacturing. A full 6-cycle chemotherapy protocol in India costs $1,500 to $3,500 compared to $6,000 to $10,000 in Kazakhstan.